Delivery Order SPE2DR25D3010-SPE2DR26F88FA
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of Valganciclovir 450 mg tablets in quantities of 60 units, with a ceiling value of $12,058.08. This non-set-aside, firm fixed-price delivery order is scheduled for completion by July 21, 2025, with fulfillment performed from AmerisourceBergen's Conshohocken, Pennsylvania location. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 18, 2025, for the supply of Valganciclovir 450 mg tablets in quantities of 60 units. This is a firm fixed price delivery order with a ceiling value of $12,934.69 and an ultimate completion date of September 19, 2025. The contract represents a non-set-aside competitive award, with performance to be fulfilled at AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $3,832.16 to AmerisourceBergen Drug Corp for the supply of Valganciclovir 450 mg tablets (60-count units) under a firm fixed price contract type. The award was made on August 25, 2025, with an ultimate completion date of August 26, 2025, and represents a competitively awarded, non-set-aside contract. Performance will take place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 25, 2025, for the supply of Valganciclovir 450 mg tablets (60-count units) with a ceiling value of $2,163.72. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and is scheduled for completion by September 26, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is the awardee, serving as the prime contractor on...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order on September 19, 2025, for the supply of Valganciclovir 450 mg tablets in unit dose packages of 20 tablets. This is a firm fixed-price contract valued at $7,046.46, with an ultimate completion date of September 22, 2025. The contract carries no set-aside designation and represents a competitive award. AmerisourceBergen will perform this delivery from its corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 8, 2025, for the supply of Valganciclovir 450 mg tablets in unit dose packaging of 20s, with a contract ceiling value of $3,787.92. This is a firm fixed-price delivery order with no set-aside designation, utilizing competitive procurement procedures. The place of performance is located in Conshohocken, Pennsylvania, with an ultimate completion date of December 9, 2025. This delivery order is issued...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Valganciclovir 450 mg tablets (60-count units) under a firm fixed price contract valued at $23,621.97, with an ultimate completion date of September 25, 2025. This non-set-aside contract was competitively awarded and will be performed at the vendor's Corporate Office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on September 18, 2025, for the supply of Valganciclovir 450 mg tablets (60-count) under a firm fixed-price contract valued at $1,081.86. This is a non-set-aside competitive award with an ultimate completion date of September 19, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and...
- The Defense Logistics Agency awarded a $2,354.68 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the supply of 450 mg valganciclovir tablets. Under this order, Amerisourcebergen will deliver 60 tablets of the specified medication to a location in Conshohocken, Pennsylvania by August 17, 2023 to support the Department of Defense's medical supply needs. As a top pharmaceutical supplier, Amerisourcebergen routinely fulfills delivery orders under the Defense Logistics...
- The Defense Logistics Agency awarded a $4,048.61 delivery order to AmerisourceBergen Drug Corp on July 22, 2025, for the supply of Valganciclovir 450 mg tablets in unit dose packaging of 20s. This is a firm fixed price, competitively awarded contract with no set-aside designation and a performance location in Conshohocken, Pennsylvania. The delivery order is associated with AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is...
- SPE2DR25D3010Indefinite Delivery Contract
- SPE2DR25D3010-SPE2DR26F88FADelivery Order
The Defense Logistics Agency awarded a delivery order valued at $2,240.22 to AmerisourceBergen Drug Corp for the supply of Valganciclovir 450 mg tablets (60-count units). This firm fixed-price contract, awarded on December 10, 2025, with an ultimate completion date of December 11, 2025, represents a non-set-aside competitive award. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under the company's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 and extending through December 2026. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical federal vendor for military and veteran healthcare systems. The company's DLA prime contract enables it to supply an extensive portfolio of pharmaceutical products across multiple therapeutic domains to support the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems worldwide. This specific delivery order for the antiviral medication Valganciclovir reflects the company's ongoing role in fulfilling pharmaceutical procurement requirements for federal medical supply chains through competitive contract mechanisms.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.2k | 12/9/25 |